$46.00

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI35194_1_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Fmoc-L-cysteic acid
Brand Name
Chem Impex
Product Number
35194
CAS
751470-47-0
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
46737376
IUPAC Name
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-sulfopropanoic acid
InChI Key
BUTKUPGRCQCTTA-INIZCTEOSA-N
SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC@@H(CS(=O)(=O)O)C(=O)O

Application

Fmoc-L-cysteic acid is widely utilized in research focused on:

Peptide Synthesis: This compound serves as a protecting group in the synthesis of peptides, allowing for the selective modification of amino acids without interfering with other functional groups.

Bioconjugation: It is used in bioconjugation processes, enabling the attachment of biomolecules to surfaces or other molecules, which is crucial in drug delivery systems and diagnostics.

Protein Engineering: Researchers leverage its properties to introduce sulfonic acid groups into proteins, enhancing their solubility and stability, which is beneficial in therapeutic applications.

Analytical Chemistry: Fmoc-L-cysteic acid is employed in various analytical techniques, including chromatography, to improve the separation and identification of complex mixtures.

Drug Development: Its unique chemical structure aids in the design of novel pharmaceuticals, particularly in targeting specific biological pathways, making it valuable in the pharmaceutical industry.

References

Structure–activity relationship of 18F-labeled PD-L1-targeting small molecule ligands: impact of radiolabeling strategy on affinity and in vivo performance

Publication Name: EJNMMI Radiopharmacy and Chemistry
Publication Date: 2025-07-01
DOI: 10.1186/s41181-025-00359-2

Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands

Publication Name: EJNMMI Radiopharmacy and Chemistry
Publication Date: 2024-02-19
DOI: 10.1186/s41181-024-00243-5